Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
1.200
+0.060 (5.26%)
Jan 9, 2026, 1:09 PM EST - Market open

ZYBT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.240.250.270.180.09
Debt / EBITDA Ratio
-2.131.300.770.44
Debt / FCF Ratio
280.273.152.20-2.35
Asset Turnover
0.310.380.420.54-
Inventory Turnover
1.621.631.662.27-
Quick Ratio
1.000.800.770.950.86
Current Ratio
1.491.311.261.411.31
Return on Equity (ROE)
-6.38%3.89%10.78%16.50%-
Return on Assets (ROA)
-3.45%2.07%5.51%8.53%-
Return on Capital (ROIC)
-3.85%2.37%6.61%10.68%-
Return on Capital Employed (ROCE)
-7.40%4.60%12.90%17.90%16.40%
Payout Ratio
-141.66%125.42%45.84%28.36%
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q